Hanmi Pharmaceutical Stocks Fall 10% After 3 Trillion Won Obesity Drug Deal
Hanmi Pharmaceutical shares fell 10% on the 25th morning despite announcing a 3 trillion won obesity drug licensing deal with Genentech the previous day. The stock traded at 486,000 won as of 9:41 AM, down 54,000 won from the prior close. The decline followed a 39% surge over the preceding three tra
Hanmi Pharmaceutical-10.01%
GateMacroTradfiHub·08-25 02:08

